The cyclin‑dependent kinase pathway involving CDK1 is a potential therapeutic target for cholangiocarcinoma
Minako Yamamura(Kanazawa University), Kenichi Harada(Kanazawa University Hospital)
Cited by 24
Related Papers
Acquired resistance to temsirolimus in human renal cell carcinoma cells is mediated by the constitutive activation of signal transduction pathways through mTORC2
|British Journal of Cancer|2013|39
Monitoring of Heat Shock Response and Phenotypic Changes in Hepatocellular Carcinoma After Heat Treatment
|Anticancer Research|2019|10